Uploaded September 2024 | Updated September 2026, 2 weeks ago
Help save the lives of blood cancer and blood disorder patients. Your support can make a huge difference!
Register now: dkms-bmst.org/GAU001
India has invented a groundbreaking cancer treatment, 'NexCAR19 CAR-T cell therapy,' approved for human trials in October 2023. This therapy can cure cancer patients in just 3-4 months and is 10 times cheaper than existing treatments. While cancer is the second leading cause of death in India, with a poor global survival ranking (around 60th), this new therapy could drastically improve outcomes. Previously led by the US and China, this advanced Indian version is not only more effective but also significantly more affordable, costing ₹4-8 crore abroad but 10 times less in India. But how is this possible and is this treatment really effective? Let's discuss.
Join us on SPOTIFY:
spotify.openinapp.co/i7q79
Follow me on X → https://x.com/gauravzthakur?s=11
Follow me on Instagram → instagram.com/gauravzthakur
Help save the lives of blood cancer and blood disorder patients. Your support can make a huge difference!
Register now: dkms-bmst.org/GAU001
India has invented a groundbreaking cancer treatment, 'NexCAR19 CAR-T cell therapy,' approved for human trials in October 2023. This therapy can cure cancer patients in just 3-4 months and is 10 times cheaper than existing treatments. While cancer is the second leading cause of death in India, with a poor global survival ranking (around 60th), this new therapy could drastically improve outcomes. Previously led by the US and China, this advanced Indian version is not only more effective but also significantly more affordable, costing ₹4-8 crore abroad but 10 times less in India. But how is this possible and is this treatment really effective? Let's discuss.
Join us on SPOTIFY:
spotify.openinapp.co/i7q79
Follow me on X → https://x.com/gauravzthakur?s=11
Follow me on Instagram → instagram.com/gauravzthakur
